Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial

Autor: Robertson, John F R, Bondarenko, Igor M, Trishkina, Ekaterina, Dvorkin, Mikhail, Panasci, Lawrence, Manikhas, Alexey, Shparyk, Yaroslav, Cardona-Huerta, Servando, Cheung, Kwok-Leung, Philco-Salas, Manuel Jesus, Ruiz-Borrego, Manuel, Shao, Zhimin, Noguchi, Shinzaburo, Rowbottom, Jacqui, Stuart, Mary, Grinsted, Lynda M, Fazal, Mehdi, Ellis, Matthew J
Zdroj: In The Lancet 17 December 2016-6 January 2017 388(10063):2997-3005
Databáze: ScienceDirect